Histogram
Visit number vs Medical Outcomes Study SF-36: Physical component summary (raw)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Baseline Visit | 159 | -0.5 | ± 0.9 | -0.3 | -3.2 | 1.1 | 10 | 169 |
Month-6 Follow-up Visit | 138 | -0.6 | ± 1.0 | -0.5 | -3.2 | 1.0 | 31 | 169 |
Month-12 Follow-up Visit | 75 | -0.5 | ± 0.9 | -0.4 | -3.2 | 1.0 | 33 | 108 |
Treatment arm vs Medical Outcomes Study SF-36: Physical component summary (raw)
Baseline Visit
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 159 | -0.5 | ± 0.9 | -0.3 | -3.2 | 1.1 | 10 | 169 |
Conservative Medical Therapy (CMT) | 42 | -0.6 | ± 1.1 | -0.3 | -3.2 | 1.1 | 2 | 44 |
CMT + Sham CPAP | 40 | -0.6 | ± 0.8 | -0.5 | -2.1 | 0.6 | 2 | 42 |
CMT + Active CPAP | 39 | -0.5 | ± 1.0 | -0.3 | -2.9 | 1.0 | 3 | 42 |
CMT + Active CPAP + Motivational Enhancement | 38 | -0.5 | ± 0.9 | -0.2 | -2.8 | 0.6 | 3 | 41 |
Treatment arm vs Medical Outcomes Study SF-36: Physical component summary (raw)
Month-6 Follow-up Visit
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 138 | -0.6 | ± 1.0 | -0.5 | -3.2 | 1.0 | 31 | 169 |
Conservative Medical Therapy (CMT) | 37 | -0.7 | ± 1.1 | -0.8 | -2.9 | 0.9 | 7 | 44 |
CMT + Sham CPAP | 33 | -0.7 | ± 1.0 | -0.6 | -2.6 | 0.7 | 9 | 42 |
CMT + Active CPAP | 35 | -0.3 | ± 1.0 | -0.2 | -2.7 | 1.0 | 7 | 42 |
CMT + Active CPAP + Motivational Enhancement | 33 | -0.6 | ± 1.0 | -0.4 | -3.2 | 0.7 | 8 | 41 |
Treatment arm vs Medical Outcomes Study SF-36: Physical component summary (raw)
Month-12 Follow-up Visit
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 75 | -0.5 | ± 0.9 | -0.4 | -3.2 | 1.0 | 33 | 108 |
Conservative Medical Therapy (CMT) | 21 | -0.6 | ± 0.9 | -0.4 | -2.4 | 0.8 | 8 | 29 |
CMT + Sham CPAP | 18 | -0.8 | ± 0.8 | -0.7 | -1.9 | 0.4 | 9 | 27 |
CMT + Active CPAP | 17 | -0.5 | ± 1.1 | -0.4 | -3.2 | 1.0 | 9 | 26 |
CMT + Active CPAP + Motivational Enhancement | 19 | -0.3 | ± 0.8 | -0.1 | -1.5 | 0.9 | 7 | 26 |
Age at visit vs Medical Outcomes Study SF-36: Physical component summary (raw)
Baseline Visit
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 159 | -0.5 | ± 0.9 | -0.3 | -3.2 | 1.1 | 10 | 169 |
46.0 to 59.0 years | 39 | -0.5 | ± 1.0 | -0.3 | -2.3 | 1.1 | 4 | 43 |
59.0 to 66.0 years | 37 | -0.7 | ± 0.9 | -0.5 | -2.5 | 0.6 | 5 | 42 |
66.0 to 69.0 years | 42 | -0.4 | ± 1.0 | -0.04 | -3.2 | 1.0 | - | 42 |
70.0 to 76.0 years | 41 | -0.6 | ± 0.9 | -0.4 | -2.9 | 1.0 | 1 | 42 |
Age at visit vs Medical Outcomes Study SF-36: Physical component summary (raw)
Month-6 Follow-up Visit
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 138 | -0.6 | ± 1.0 | -0.5 | -3.2 | 1.0 | 31 | 169 |
46.0 to 60.0 years | 29 | -0.8 | ± 1.2 | -0.7 | -2.9 | 0.9 | 14 | 43 |
60.0 to 66.0 years | 34 | -0.6 | ± 0.8 | -0.5 | -2.6 | 0.5 | 8 | 42 |
66.0 to 70.0 years | 39 | -0.5 | ± 1.0 | -0.4 | -2.8 | 0.7 | 3 | 42 |
70.0 to 77.0 years | 36 | -0.5 | ± 1.0 | -0.4 | -3.2 | 1.0 | 6 | 42 |
Age at visit vs Medical Outcomes Study SF-36: Physical component summary (raw)
Month-12 Follow-up Visit
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 75 | -0.5 | ± 0.9 | -0.4 | -3.2 | 1.0 | 33 | 108 |
47.0 to 60.0 years | 14 | -1.1 | ± 1.2 | -1.3 | -3.2 | 0.7 | 13 | 27 |
60.0 to 66.0 years | 21 | -0.5 | ± 0.6 | -0.4 | -1.5 | 0.9 | 6 | 27 |
66.0 to 70.0 years | 20 | -0.3 | ± 0.9 | -0.2 | -2.4 | 1.0 | 7 | 27 |
71.0 to 77.0 years | 20 | -0.5 | ± 0.9 | -0.2 | -1.9 | 0.7 | 7 | 27 |
Gender vs Medical Outcomes Study SF-36: Physical component summary (raw)
Baseline Visit
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 159 | -0.5 | ± 0.9 | -0.3 | -3.2 | 1.1 | 10 | 169 |
Male | 106 | -0.3 | ± 0.8 | -0.07 | -2.5 | 1.1 | 4 | 110 |
Female | 53 | -1.0 | ± 1.0 | -1.2 | -3.2 | 1.0 | 6 | 59 |
Gender vs Medical Outcomes Study SF-36: Physical component summary (raw)
Month-6 Follow-up Visit
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 138 | -0.6 | ± 1.0 | -0.5 | -3.2 | 1.0 | 31 | 169 |
Male | 94 | -0.4 | ± 0.9 | -0.1 | -2.7 | 0.9 | 16 | 110 |
Female | 44 | -1.1 | ± 1.1 | -1.1 | -3.2 | 1.0 | 15 | 59 |
Gender vs Medical Outcomes Study SF-36: Physical component summary (raw)
Month-12 Follow-up Visit
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 75 | -0.5 | ± 0.9 | -0.4 | -3.2 | 1.0 | 33 | 108 |
Male | 50 | -0.3 | ± 0.9 | -0.2 | -2.6 | 1.0 | 22 | 72 |
Female | 25 | -0.9 | ± 0.9 | -1.0 | -3.2 | 0.7 | 11 | 36 |
Race vs Medical Outcomes Study SF-36: Physical component summary (raw)
Baseline Visit
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 158 | -0.5 | ± 0.9 | -0.3 | -3.2 | 1.1 | 10 | 168 |
White | 144 | -0.5 | ± 0.9 | -0.3 | -3.2 | 1.1 | 8 | 152 |
American Indian or Alaskan Native | - | - | - | - | - | - | - | - |
Black or African American | 9 | -0.6 | ± 1.2 | -0.2 | -2.9 | 0.7 | 2 | 11 |
Asian | 4 | -0.3 | ± 1.3 | 0.1 | -2.1 | 0.7 | - | 4 |
Native Hawaiian or other Pacific islander | - | - | - | - | - | - | - | - |
Other | 1 | -0.5 | - | -0.5 | -0.5 | -0.5 | - | 1 |
Multiple | - | - | - | - | - | - | - | - |
Race vs Medical Outcomes Study SF-36: Physical component summary (raw)
Month-6 Follow-up Visit
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 137 | -0.6 | ± 1.0 | -0.5 | -3.2 | 1.0 | 31 | 168 |
White | 128 | -0.6 | ± 1.0 | -0.5 | -3.2 | 1.0 | 24 | 152 |
American Indian or Alaskan Native | - | - | - | - | - | - | - | - |
Black or African American | 6 | -1.1 | ± 1.1 | -1.3 | -2.5 | 0.4 | 5 | 11 |
Asian | 3 | -0.4 | ± 1.2 | 0.2 | -1.8 | 0.4 | 1 | 4 |
Native Hawaiian or other Pacific islander | - | - | - | - | - | - | - | - |
Other | - | - | - | - | - | - | 1 | 1 |
Multiple | - | - | - | - | - | - | - | - |
Race vs Medical Outcomes Study SF-36: Physical component summary (raw)
Month-12 Follow-up Visit
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 75 | -0.5 | ± 0.9 | -0.4 | -3.2 | 1.0 | 33 | 108 |
White | 69 | -0.5 | ± 0.9 | -0.4 | -3.2 | 1.0 | 26 | 95 |
American Indian or Alaskan Native | - | - | - | - | - | - | - | - |
Black or African American | 5 | -1.0 | ± 1.1 | -1.4 | -2.2 | 0.7 | 4 | 9 |
Asian | 1 | 0.8 | - | 0.8 | 0.8 | 0.8 | 2 | 3 |
Native Hawaiian or other Pacific islander | - | - | - | - | - | - | - | - |
Other | - | - | - | - | - | - | 1 | 1 |
Multiple | - | - | - | - | - | - | - | - |